Skip to main content

Table 3 VTEs in different treatment phases and Grades according to CTCAE v4.0

From: High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08

GradeOverall % (N = 29)Preoperative CT & CRT % (N = 21a)Postoperative % (N = 8)
G10% (0)0% (0)0% (0)
G245% (13)52% (11)25% (2)
G345% (13)48% (10)38% (3)
G40% (0)0% (0)0% (0)
G510% (3)0% (0)38% (3)
  1. Abbreviations: G Grade, CTCAE Common Toxicity Criteria for Adverse Events
  2. aOne patient had two separate VTEs in the RCT phase